Anyone who follows the sports world is well-aware of the concept of doping, in which athletes participate to establish an edge over the competition. This goes back a long ways and includes more famous examples like the East German Olympic machine, and the sprinter Ben Johnson, but also the more recent examples of Todd Landis, Marion Jones and, of course, Barry Bonds.
Competition seems to do that to people, clouding their judgment, confusing their ideals, pushing them to a point where it seems almost immoral not to give yourself any and every possible advantage. Well, doping is extending beyond the physical and entering the realm of cognitive capacity. A new commentary in Nature, written by Barbara Sahakian and Sharon Morein-Zamir of Cambridge, argues that the increased use of “cognitive-enhancing drugs” poses a number of serious ethical issues that can no longer be ignored.